{"SLR NAME":"Outcomes of mechanical ventilation among patients with COVID-19 adult respiratory distress syndrome: a systematic review and meta-analysis","References":[{"title1":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study","References":[{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Return of the Coronavirus: 2019-nCoV","References":[{"title3":"Wuhan Municipal Health and Health Commission's Briefing on the Current Pneumonia Epidemic Situation in Our City"},{"title3":"New Virus Discovered by Chinese Scientists Investigating Pneumonia Outbreak"},{"title3":"WHO Statement Regarding Cluster of Pneumonia Cases in Wuhan, China"},{"title3":"Novel 2019 Coronavirus Genome"},{"title3":"2020 Coronavirus"},{"title3":"Novel Coronavirus:Japan (ex-China)"},{"title3":"Laboratory Testing for 2019 Novel Coronavirus (2019-nCoV) in Suspected Human Cases"},{"title3":"Estimating the Potential Total Number of Novel Coronavirus (2019-nCoV) Cases in Wuhan City, China"},{"title3":"Wuhan Municipal Commission of Health and Health on Pneumonia of New Coronavirus Infection"},{"title3":"Super-spreaders in infectious diseases"},{"title3":"Wuhan Virus: China Locks down Huanggang, Shuts Down Railway Station in Ezhou after Wuhan Lockdown"},{"title3":"Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human"},{"title3":"nCoV's Relationship to Bat Coronaviruses and Recombination Signals No Snakes"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China"},{"title3":"Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus"},{"title3":"Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus"},{"title3":"Viral Loads in Clinical Specimens and SARS Manifestations"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study"},{"title3":"Risk Factors for Fatal Middle East Respiratory Syndrome Coronavirus Infections in Saudi Arabia: Analysis of the WHO Line List, 2013-2018"},{"title3":"SARS Severe Acute Respiratory Syndrome"},{"title3":"MERS-CoV"},{"title3":"Preliminary Phylogenetic Analysis of 11 nCoV2019 Genomes, 2020-01-19"},{"title3":"Genomic Epidemiology of Novel Coronavirus (nCoV) Using Data Generated by Fudan University, China CDC, Chinese Academy of Medical Sciences, Chinese Academy of Sciences and the Thai National Institute of Health Shared via GISAID"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Jumping species-a mechanism for coronavirus persistence and survival"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Functional assessment of cell entry and receptor usage for lineage B beta-coronaviruses, including 2019-nCoV"},{"title3":"Viruses and Koch's Postulates"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4"},{"title3":"Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques"},{"title3":"15 Medical Staff in Wuhan Confirmed New Coronavirus Pneumonia, and Another Suspected"},{"title3":"Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review"},{"title3":"MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease"},{"title3":"Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"CHP closely monitors cluster of pneumonia cases on Mainland"},{"title3":"CHP provides further information on cluster of pneumonia cases in Wuhan"},{"title3":"Wuhan wet market closes amid pneumonia outbreak"},{"title3":"Viral load in patients infected with pandemic H1N1 2009 influenza A virus"},{"title3":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study"},{"title3":"Evaluation of NxTAG Respiratory pathogen panel and comparison with xTAG respiratory viral panel fast v2 and film array respiratory panel for detecting respiratory pathogens in nasopharyngeal aspirates and swine/avian-origin influenza A subtypes in culture isolates"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type I interferons"},{"title3":"High prevalence of four novel astrovirus genotype species identified from rodents in China"},{"title3":"Metagenomic analysis of viromes of dromedary camel fecal samples reveals large number and high diversity of circoviruses and picobirnaviruses"},{"title3":"Identification of a novel bat papillomavirus by metagenomics"},{"title3":"Metagenomic nanopore sequencing of influenza virus direct from clinical respiratory samples"},{"title3":"Severe acute respiratory syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection"},{"title3":"A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China"},{"title3":"Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Viral loads in clinical specimens and SARS manifestations"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus"},{"title3":"Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43"}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"New coronavirus pneumonia prevention and control program (6th ed) (in Chinese). 2020. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf.","References":[]},{"title2":"World Health Organization. Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance. 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.","References":[]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study","References":[]},{"title2":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. 2003. https://www.who.int/csr/sars/country/table2004_04_21/en/.","References":[]},{"title2":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). 2019. https://www.who.int/emergencies/mers-cov/en/.","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"}]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series [correction in: BMJ 2020;368:m792]","References":[]},{"title2":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","References":[{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"}]},{"title2":"Can we contain the COVID-19 outbreak with the same measures as for SARS?","References":[{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak"},{"title3":"Battling 21st-century scourges with a 14th-century toolbox"},{"title3":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome"},{"title3":"Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore"},{"title3":"Modelling strategies for controlling SARS outbreaks"},{"title3":"Household transmission of SARS, 2003"},{"title3":"Epidemiology and control of SARS in Singapore"},{"title3":"Hospitalized patients with bacterial infections: a potential focus of SARS transmission during an outbreak"},{"title3":"Public health and ethical considerations in planning for quarantine"},{"title3":"Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto"},{"title3":"SARS: public health measures in Hong Kong"},{"title3":"Controlling SARS: a review on China's response compared with other SARS-affected countries"},{"title3":"The impact of public health control measures during the SARS epidemic in mainland China"},{"title3":"A tale of two cities: community psychobehavioral surveillance and related impact on outbreak control in Hong Kong and Singapore during the severe acute respiratory syndrome epidemic"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"SARS in healthcare facilities, Toronto and Taiwan"},{"title3":"SARS in Singapore:key lessons from an epidemic"},{"title3":"Experience of severe acute respiratory syndrome in Singapore: importation of cases, and defense strategies at the airport"},{"title3":"The severe acute respiratory syndrome: impact on travel and tourism"},{"title3":"SARS to novel coronavirus:old lessons and new lessons"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response"},{"title3":"Travelers give wings to novel coronavirus (2019-nCoV)"},{"title3":"Potential for global spread of a novel coronavirus from China"},{"title3":"Pneumonia of unknown etiology in Wuhan, China: potential for international spread via commercial air travel"},{"title3":"Asymptomatic SARS coronavirus infection among healthcare workers, Singapore"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV)"},{"title3":"The reproductive number of COVID-19 is higher compared to SARS coronavirus"},{"title3":"COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures"},{"title3":"The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19):China, 2020. China CDC Weekly 2020"}]},{"title2":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"SARS coronavirus sequencing"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong"},{"title3":"Case definitions for surveillance of severe acute respiratory syndrome (SARS): revised 1 May 2003"},{"title3":"Pneumonia due to viral and atypical organisms and their sequelae"},{"title3":"Pneumonia: high-resolution CT findings in 114 patients"},{"title3":"Imaging of pneumonia: trends and algorithms"},{"title3":"Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital"},{"title3":"Differentiation of bacterial and viral pneumonia in children"},{"title3":"Hospital infection control guidance for severe acute respiratory syndrome (SARS): revised 24 April 2003"},{"title3":"Personal view of SARS: confusing definition, confusing diagnoses"},{"title3":"The immediate psychological and occupational impact of the 2003 SARS outbreak in teaching hospital"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Cluster of severe acute respiratory syndrome cases among protected health-care workers: Toronto, Canada, April 2003"},{"title3":"Interim domestic guidance for management of exposures to severe acute respiratory syndrome (SARS) for health-care settings"},{"title3":"Clinical course and management of SARS in health care workers in Toronto: a case series"},{"title3":"Identification and containment of an outbreak of SARS in a community hospital"},{"title3":"Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"An outbreak of coronavirus OC43 respiratory infection in Normandy, France"},{"title3":"Severe acute respiratory syndrome: clinical outcome and prognostic correlates"}]}]},{"title1":"Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study","References":[{"title2":"Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020. 10.1002/jmv.25678.","References":[]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China","References":[{"title3":"The Middle East Respiratory Syndrome (MERS)"},{"title3":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features"},{"title3":"Pneumonia in China: lack of information raises concerns among Hong Kong health workers"},{"title3":"Taking forward a' One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential"},{"title3":"ProMED &quot;Novel coronavirus - China (01): (HU) WHO, phylogenetic tree&quot;. Archive Number: 20200112.6885385. Accessed 13 Jan 2020. https://www.ecohealthalliance.org/2020/01/phylogenetic-analysis-shows-novel-wuhan-coronavirus-clusters-with-sars."}]},{"title2":"Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold. JAMA. 2020. 10.1001/jama.2020.0757.","References":[]},{"title2":"WHO. Situation report-55. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200315-sitrep-55-covid-19.pdf?sfvrsn=33daa5cb_6. Accessed 12 Apr 2020.","References":[]},{"title2":"WHO: Shortage of personal protective equipment endangering health workers worldwide. https://www.who.int/news-room/detail/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide. Accessed 12 Apr 2020.","References":[]},{"title2":"Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health. 2020. 10.1016/S2214-109X(20)30068-1.","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. 10.1016/S2213-2600(20)30079-5.","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","References":[{"title3":"The role of glucocorticoids as adjunctive treatment for sepsis in the modern era"},{"title3":"Corticosteroids for treating sepsis"},{"title3":"Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis"},{"title3":"Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis"},{"title3":"Reevaluating the role of corticosteroids in septic shock: an updated meta-analysis of randomized controlled trials"},{"title3":"Can corticosteroids reduce the mortality of patients with severe sepsis? A systematic review and meta-analysis"},{"title3":"Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature"},{"title3":"Corticosteroids in sepsis: an updated systematic review and meta-analysis"},{"title3":"Effect of adjunctive corticosteroids on clinical outcomes in adult patients with septic shock-a meta-analysis of randomized controlled trials and trial sequential analysis"},{"title3":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis"},{"title3":"Adjunctive glucocorticoid therapy in patients with septic shock"},{"title3":"Hydrocortisone plus fludrocortisone for adults with septic shock"},{"title3":"2001 sccm/esicm/accp/ats/sis international sepsis definitions conference"},{"title3":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis"},{"title3":"Sepsis definitions: time for change"},{"title3":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)"},{"title3":"Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study"},{"title3":"Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion CriteriaA Post Hoc Analysis of the ADRENAL Trial"},{"title3":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)"},{"title3":"Using big data to emulate a target trial when a randomized trial is not available"},{"title3":"The eICU Collaborative Research Database, a freely available multi-center database for critical care research"},{"title3":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis"},{"title3":"FDA-Approved Drugs: SOLU-MEDROL U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process"},{"title3":"FDA-Approved Drugs: SOLU-CORTEF U.S. FOOD &amp; DRUG Web site. Accessed 18 April 2020 https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=009866"},{"title3":"Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial"},{"title3":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone"},{"title3":"Immortal time bias in pharmacoepidemiology"},{"title3":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial"},{"title3":"Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock"},{"title3":"Hydrocortisone therapy for patients with septic shock"},{"title3":"National analysis of sepsis hospitalizations and factors contributing to sepsis in-hospital mortality in Canada"},{"title3":"Glucose variability and mortality in patients with sepsis"},{"title3":"Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock"},{"title3":"The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis"},{"title3":"Adjusted survival curves with inverse probability weights"},{"title3":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples"},{"title3":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies"},{"title3":"Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis"},{"title3":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial"},{"title3":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock"},{"title3":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial"},{"title3":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial"},{"title3":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial"},{"title3":"The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study"},{"title3":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"Corticosteroids for treating sepsis in children and adults"},{"title3":"Steroids in the treatment of clinical septic shock"},{"title3":"Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Reduced cortisol metabolism during critical illness"},{"title3":"Cortisol levels and mortality in severe sepsis"},{"title3":"Why Test for Proportional Hazards?"},{"title3":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes"}]},{"title2":"KDIGO clinical practice guidelines for acute kidney injury","References":[]},{"title2":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020. 10.1001/jama.2020.2648.","References":[]},{"title2":"National Health Commission of the People's Republic of China. Feb 27: daily briefing on novel coronavirus cases in China. http://en.nhc.gov.cn/2020-02/27/c_76975.htm. Accessed 12 Apr 2020.","References":[]},{"title2":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for C. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. 10.1056/NEJMoa2002032.","References":[]},{"title2":"Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study","References":[]},{"title2":"Lessons to learn from epidemiologic studies in ARDS","References":[]},{"title2":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. 10.1001/jama.2020.1585.","References":[]},{"title2":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study","References":[]},{"title2":"Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission","References":[{"title3":"Primary immunodeficiency diseases due to defects in lymphocytes"},{"title3":"Infection by human immunodeficiency virus-CD4 is not enough"},{"title3":"The pathophysiology and treatment of sepsis"},{"title3":"Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony"},{"title3":"Sepsis induces early alterations in innate immunity that impact mortality to secondary infection"},{"title3":"Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock"},{"title3":"Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction"},{"title3":"Decrease in circulating dendritic cells predicts fatal outcome in septic shock"},{"title3":"The delayed hypersensitivity response and host resistance in surgical patients. 20 years later"},{"title3":"Apoptosis and caspases regulate death and inflammation in sepsis"},{"title3":"Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans"},{"title3":"Early assessment of leukocyte alterations at diagnosis of septic shock"},{"title3":"Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit"},{"title3":"Risk factors in postoperative sepsis: significance of preoperative lymphocytopenia"},{"title3":"Persistent lymphopenia after diagnosis of sepsis predicts mortality"},{"title3":"HELICS: a European project to standardise the surveillance of hospital acquired infection, 1994-1995"},{"title3":"Propensity scores in intensive care and anaesthesiology literature: a systematic review"},{"title3":"What's new in the quantification of causal effects from longitudinal cohort studies: a brief introduction to marginal structural models for intensivists"},{"title3":"Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study"},{"title3":"Downregulation of CD40 ligand response in monocytes from sepsis patients"},{"title3":"Anti-inflammatory cytokine profile and mortality in febrile patients"},{"title3":"Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome"},{"title3":"Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients"},{"title3":"Immunoparalysis as a cause for invasive aspergillosis?"},{"title3":"Cytomegalovirus reactivation in critically ill immunocompetent patients"},{"title3":"A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1"},{"title3":"Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies"},{"title3":"Immunosuppression in patients who die of sepsis and multiple organ failure"},{"title3":"Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients"},{"title3":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach"},{"title3":"Decreased T-cell repertoire diversity in sepsis: a preliminary study"},{"title3":"Transient lymphopenia in acutely unwell young infants"},{"title3":"Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure"},{"title3":"Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma"},{"title3":"Relationships between T lymphocyte apoptosis and anergy following trauma"},{"title3":"Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients"},{"title3":"Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock"},{"title3":"A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis"}]},{"title2":"Association of lymphopenia with short term outcomes of sepsis patients; a brief report","References":[{"title3":"Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis"},{"title3":"Review article: Sepsis in the emergency department - Part 1: Definitions and outcomes"},{"title3":"The effect of fluid therapy on hemodynamic and venous blood gas parameters in patients with septic shock"},{"title3":"Persistent lymphopenia after diagnosis of sepsis predicts mortality"},{"title3":"Clinical diagnosis of sepsis and the combined use of biomarkers and culture- and non-culture-based assays"},{"title3":"Correlation of Blood Gas Parameters with Central Venous Pressure in Patients with Septic Shock; a Pilot Study"},{"title3":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy"},{"title3":"Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges"},{"title3":"Leukocyte apoptosis and its significance in sepsis and shock"},{"title3":"Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients"},{"title3":"Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure"},{"title3":"Early assessment of leukocyte alterations at diagnosis of septic shock"},{"title3":"Relation between lymphopenia and bacteraemia in UK adults with medical emergencies"},{"title3":"Lymphopenia Is Associated With Worse Outcome In Patients With Severe Sepsis"},{"title3":"Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naive T-cells but no enduring cell-autonomous defects in T-cell function"},{"title3":"Interleukin-10/lymphocyte ratio predicts mortality in severe septic patients"}]},{"title2":"Li Z, Wu M, Guo J, Yao J, Liao X, Song S, Han M, Li J, Duan G, Zhou Y, Wu X, Zhou Z, Wang T, Hu M, Chen X, Fu Y, Lei C, Dong H, Zhou Y, Jia H, Chen X, Yan J (2020) Caution on kidney dysfunctions of 2019-nCoV patients. medRxiv:2020.2002.2008.20021212. doi:10.1101/2020.02.08.20021212.","References":[]},{"title2":"Critically ill patients with severe acute respiratory syndrome","References":[{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"A comprehensive review of the use and understanding of airway pressure release ventilation"},{"title3":"Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome"},{"title3":"The use of bronchoscopy in critically ill patients: considerations and complications"},{"title3":"Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome"},{"title3":"Safety of research bronchoscopy in critically ill patients"},{"title3":"Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients"},{"title3":"Bronchoscopy in the Intensive Care Unit"},{"title3":"The effect of fibreoptic bronchoscopy in acute respiratory distress syndrome: experimental evidence from a lung model"},{"title3":"Changes in pulmonary mechanics after fiberoptic bronchoalveolar lavage in mechanically ventilated patients"},{"title3":"Effects on respiratory mechanics of bronchoalveolar lavage in mechanically ventilated patients"}]},{"title2":"Chest radiography versus lung ultrasound for identification of acute respiratory distress syndrome: a retrospective observational study","References":[{"title3":"ARDS Definition Task Force, ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526-33."},{"title3":"Outcomes of the acute respiratory distress syndrome using the Kigali modification of the Berlin definition"},{"title3":"Accuracy of the chest radiograph to identify bilateral pulmonary infiltrates consistent with the diagnosis of acute respiratory distress syndrome using computed tomography as reference standard"},{"title3":"Lung ultrasound in acute respiratory distress syndrome and beyond"},{"title3":"Review article: use of ultrasound in the developing world"},{"title3":"Accuracy of lung ultrasonography versus chest radiography for the diagnosis of adult community-acquired pneumonia: review of the literature and meta-analysis"},{"title3":"Accuracy of lung ultrasonography in the diagnosis of pneumonia in adults: systematic review and meta-analysis"},{"title3":"Comparative diagnostic performances of auscultation, chest radiography, and lung ultrasonography in acute respiratory distress syndrome"},{"title3":"The BLUE-points: three standardized points used in the BLUE-protocol for ultrasound assessment of the lung in acute respiratory failure"},{"title3":"Simplified lung ultrasound protocol shows excellent prediction of extravascular lung water in ventilated intensive care patients"},{"title3":"Pulmonary ultrasound and pulse oximetry versus chest radiography and arterial blood gas analysis for the diagnosis of acute respiratory distress syndrome: a pilot study"},{"title3":"External confirmation and exploration of the Kigali modification for diagnosing moderate or severe ARDS"},{"title3":"Coudroy R, Frat JP, Boissier F, Contou D, Robert R, Thille AW. Early identification of acute respiratory distress disorder in the absence of positive pressure ventilation: implications for revision of the berlin criteria for acute respiratory distress syndrome. Crit Care Med. 2018;46(4):540-6."},{"title3":"The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material"},{"title3":"Lung ultrasound training: curriculum implementation and learning trajectory among respiratory therapists"},{"title3":"International evidence-based recommendations for point-of-care lung ultrasound"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"Ultrasound assessment of lung aeration loss during a successful weaning trial predicts postextubation distress"},{"title3":"Interobserver variability in applying a radiographic definition for ARDS"},{"title3":"Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome"},{"title3":"Lung water assessment by lung ultrasonography in intensive care: a pilot study"}]},{"title2":"Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A, Network C-LI. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020. 10.1001/jama.2020.5394.","References":[]},{"title2":"Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA. 2020. 10.1001/jama.2020.4326.","References":[]}]},{"title1":"Covid-19 in Critically Ill Patients in the Seattle Region  Case Series","References":[{"title2":"Novel coronavirus : China","References":[]},{"title2":"Coronavirus COVID-19 global cases","References":[{"title3":"ThWorld Health Organization Declares COVID-19 a 'Pandemic.' Here's What That Means"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Daily Report by Baidu"},{"title3":"Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea"},{"title3":"False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence"},{"title3":"A Systematic Review of COVID-19 Epidemiology Based on Current Evidence"},{"title3":"Contributions to the mathematical theory of epidemics:I"},{"title3":"Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak"},{"title3":"European Centre for Disease Prevention and Control"},{"title3":"Wikipedia (English) &quot;COVID-19 Testing&quot;"},{"title3":"Greedy Function Approximation: A Gradient Boosting Machine"},{"title3":"Scikit-learn: Machine Learning in Python"},{"title3":"Scikit-Learn"},{"title3":"Python Software Foundation"},{"title3":"Average Detection Rate of SARS-CoV-2 Infections is Estimated around Six Percent"},{"title3":"On the origin and continuing evolution of SARS-CoV-2"},{"title3":"CCR5Delta32 mutation and HIV infection: Basis for curative HIV therapy"},{"title3":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor"},{"title3":"X chromosome gene expression in human tissues: Male and female comparisons"},{"title3":"The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk: A meta-analysis involving 14,122 patients"},{"title3":"The ACE2 G8790A Polymorphism: Involvement in Type 2 Diabetes Mellitus Combined with Cerebral Stroke"},{"title3":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance"},{"title3":"The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients"},{"title3":"Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients"},{"title3":"SNPedia: A wiki supporting personal genome annotation, interpretation and analysis"},{"title3":"The BCG World Atlas: A database of global BCG vaccination policies and practices"},{"title3":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity"},{"title3":"Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis"}]},{"title2":"First case of 2019 novel coronavirus in the United States.","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"2019 Novel coronavirus outbreak (COVID-19)","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30]"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Detection of SARS-CoV-2 in different types of clinical specimens"},{"title3":"Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure"},{"title3":"Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J (2020) Chest CT for typical 2019nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 10.1148/radiol.2020200343"},{"title3":"Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion"},{"title3":"Chest computed tomography and lung ultrasound findings in COVID-19 pneumonia: a pocket review for non-radiologists"},{"title3":"Lung ultrasound may support diagnosis and monitoring of COVID-19 pneumonia"},{"title3":"Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study"},{"title3":"Performance of radiologists in differentiating COVID-19 from non-COVID-19 viral pneumonia at chest CT"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Is there a role for lung ultrasound during the COVID-19 pandemic"},{"title3":"Thoracic ultrasonography: a narrative review"},{"title3":"Proposal for international standardization of the use of lung ultrasound for patients with COVID-19: a simple, quantitative, reproducible method"},{"title3":"Detection of SARS-coV-2 in different types of clinical specimens"},{"title3":"On Lung Ultrasound patterns specificity in the management of COVID-19 patients"},{"title3":"Point-of-care lung ultrasound in patients with COVID-19:a narrative review"},{"title3":"DGRT n. 669 del 18-06-2018. Allegato A &quot;Modello organizzativo dell'Emergenza Pediatrica Ospedaliera. Linee di indirizzo.&quot; (2018) http://www.quotidianosanita.it/allegati/allegato3489968.pdf"},{"title3":"DGRT n.1380/2016 &quot;Reti cliniche tempo-dipendenti di cui al D.M. 70/2015. Approvazione documenti di programmazione delle reti regionali.&quot; Allegato C. (2016) https://www.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5135888&amp;nomeFile=Delibera_n.1380_del_27-12-2016-Allegato-C"},{"title3":"World Health Organization (2020) Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance. 20 March 2020. WHO/2019-nCoV/SurveillanceGuidance/2020.6"},{"title3":"World Health Organization (2020) Laboratory testing of human suspected cases of novel coronavirus (nCOV) infection: interim guidance January 12, 2020. https://apps.who.int/iris/bitstream/handle/10665/330374/WHO-2019-nCoV-laboratory-2020.1-eng.pdf"},{"title3":"Ministero della Salute (2016) Ministero della Salute:Assistenza, ospedale e territorio:118 e Pronto Soccorso:I codici colore gravita (triage). Ref type: online source"},{"title3":"Updated Manchester triage system published this month"},{"title3":"Accademia di Ecografia Toracica:Pleural Hubbers Team (2019) COVID-19 MANAGEMENT poster. https://www.ordine-medici-firenze.it/modulistica-docman/varie/311-adet/file. Ref type: online source"},{"title3":"World Health Organization (2020) Clinical management of COVID-19. Interim guidance 27 May 2020. WHO/2019-nCoV/clinical/2020.5"},{"title3":"CT imaging features of novel coronavirus (2019-nCoV)"},{"title3":"Societa Italiana di Emergenza Urgenza (SIMEU) (2019) Rapporto Prima Linea COVID-19_ecografia. https://www.simeu.it/w/articoli/leggiArticolo/4031/leggi. Ref type: online source"},{"title3":"http://www301.regione.toscana.it/bancadati/atti/Contenuto.xml?id=5247300&amp;nomeFile=Ordinanza_del_Presidente_n.14_del_17-03-2020-Allegato-A (2020). Ref type: online source"},{"title3":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal"}]},{"title2":"Cryptic transmission of novel coronavirus revealed by genomic epidemiology","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response.","References":[]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State.","References":[]},{"title2":"Priorities for the US health community responding to COVID-19.","References":[]},{"title2":"Acute respiratory distress syndrome: the Berlin Definition.","References":[]},{"title2":"Coronavirus disease 2019 (COVID-19)","References":[]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.","References":[{"title3":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. Available from: https://www.who.int/health-topics/coronavirus "},{"title3":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological. [Accessed 21 Jan 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319 "},{"title3":"de Groot RJ, Baker SC, Baric R, Enjuanes L, Gorbalenya AE, Holmes KV, et al. Family Coronaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. London; Waltham: Academic Press; 2012. p. 806-20."},{"title3":"The severe acute respiratory syndrome."},{"title3":"World Health Organization. (WHO. Novel Coronavirus (2019-nCoV). Situation report - 1. Geneva: WHO; 21 Jan 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf "},{"title3":"SARS testing: First past the post."},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China."},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction."},{"title3":"Coordinated implementation of chikungunya virus reverse transcription-PCR."},{"title3":"Assay optimization for molecular detection of Zika virus."},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences."},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission."},{"title3":"Hosts and sources of endemic human coronaviruses."},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS."},{"title3":"Origin and evolution of pathogenic coronaviruses."},{"title3":"The European Virus Archive goes global: A growing resource for research."},{"title3":"Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data."},{"title3":"Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018."},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV."},{"title3":"Advancing preparedness for clinical research during infectious disease epidemics."}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Early neuromuscular blockade in the acute respiratory distress syndrome.","References":[{"title3":"Incidence and mortality of acute respiratory distress syndrome in children: a systematic review and meta-analysis"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Ventilator-induced lung injury: from the bench to the bedside"},{"title3":"Ventilator-associated lung injury"},{"title3":"Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials"},{"title3":"Early hepatic dysfunction is associated with a worse outcome in patients presenting with acute respiratory distress syndrome: a post-hoc analysis of the ACURASYS and PROSEVA studies"},{"title3":"Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome"},{"title3":"Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome"},{"title3":"Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome"},{"title3":"Short-term effects of neuromuscular blockade on global and regional lung mechanics, oxygenation and ventilation in pediatric acute hypoxemic respiratory failure"},{"title3":"Early use of adjunctive therapies for pediatric acute respiratory distress syndrome: a PARDIE study"},{"title3":"Acute lung injury in children: therapeutic practice and feasibility of international clinical trials"},{"title3":"Mechanical ventilation strategies in children with acute lung injury: a survey on stated practice pattern*"},{"title3":"Nonpulmonary treatments for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference"},{"title3":"Recommendations for mechanical ventilation of critically ill children from the Paediatric Mechanical Ventilation Consensus Conference (PEMVECC)"},{"title3":"Early Neuromuscular Blockade in Children with Pediatric Acute Respiratory Distress Syndrome"},{"title3":"Neuromuscular manifestations of critical illness"},{"title3":"Prospective documentation of sedative, analgesic, and neuromuscular blocking agent use in infants and children in the intensive care unit: a multicenter perspective"},{"title3":"Continuous-infusion neuromuscular blocking agents in critically ill neonates and children"},{"title3":"Allergic risk during paediatric anaesthesia"},{"title3":"ICU-Acquired Weakness Is Associated With Differences in Clinical Outcomes in Critically Ill Children"},{"title3":"Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference"},{"title3":"The COMFORT behaviour scale detects clinically meaningful effects of analgesic and sedative treatment"},{"title3":"Nonrespiratory pediatric logistic organ dysfunction-2 score is a good predictor of mortality in children with acute respiratory failure"},{"title3":"Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria"},{"title3":"Reproducibility of childhood respiratory symptom questions"},{"title3":"Performance of commonly used respiratory questionnaire items in a cohort of infants born preterm"},{"title3":"Diagnosis and management of critical illness polyneuropathy and critical illness myopathy"},{"title3":"An Evaluation of Various Ventilator-Associated Infection Criteria in a PICU"},{"title3":"Consensus statement for inert gas washout measurement using multiple- and single- breath tests"},{"title3":"Reappraisal of Ventilator-Free Days in Critical Care Research"},{"title3":"Relationship between the functional status scale and the pediatric overall performance category and pediatric cerebral performance category scales"},{"title3":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support"},{"title3":"The REDCap consortium: Building an international community of software platform partners"},{"title3":"How safe is non-bronchoscopic bronchoalveolar lavage in critically ill mechanically ventilated children?"},{"title3":"Nonpulmonary Treatments for Pediatric Acute Respiratory Distress Syndrome: Proceedings From the Pediatric Acute Lung Injury Consensus Conference"},{"title3":"Functional Status Scale: new pediatric outcome measure"},{"title3":"Relevant Outcomes in Pediatric Acute Respiratory Distress Syndrome Studies"},{"title3":"Pediatric origins of adult lung disease. 1. The contribution of airway development to paediatric and adult lung disease"},{"title3":"Childhood respiratory illness and lung function at ages 14 and 50 years: childhood respiratory illness and lung function"},{"title3":"Early life origins of chronic obstructive pulmonary disease"},{"title3":"Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study"},{"title3":"Reduced PICU respiratory admissions during COVID-19"},{"title3":"Unplanned and medical admissions to pediatric intensive care units significantly decreased during COVID-19 outbreak in Northern Italy"}]},{"title2":"Prone positioning in severe acute respiratory distress syndrome.","References":[]},{"title2":"Bacterial coinfection in influenza: a grand rounds review.","References":[]},{"title2":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.","References":[{"title3":"multi-country outbreak:update 34"},{"title3":"SARS coronavirus sequencing"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Atypical pneumonia"},{"title3":"Guideline on management of severe acute respiratory syndrome (SARS)"},{"title3":"HA guidelines on severe acute respiratory syndrome"},{"title3":"The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination"},{"title3":"APACHE II: a severity of disease classification system"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus acute respiratory distress syndrome"},{"title3":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Radiological appearances of cytomegalovirus infections"},{"title3":"A case of influenza bronchiolitis complicated by pneumomediastinum and subcutaneous emphysema"}]},{"title2":"Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients.","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome.","References":[]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis.","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.","References":[]},{"title2":"Care of the critically ill and injured during pandemics and disasters: groundbreaking results from the Task Force on Mass Critical Care.","References":[]},{"title2":"Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.","References":[{"title3":"Definitive care for the critically ill during a disaster: current capabilities and limitations: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Refining surge capacity: conventional, contingency, and crisis capacity"},{"title3":"European Society of Intensive Care Medicine's Task Force for intensive care unit triage during an influenza epidemic or mass disaster. Chapter 2. Surge capacity and infrastructure considerations for mass critical care. Recommendations and standard operating procedures for intensive care unit and hospital preparations for an influenza epidemic or mass disaster"},{"title3":"Health care facility and community strategies for patient care surge capacity"},{"title3":"Task Force for Mass Critical Care. Summary of suggestions from the Task Force for Mass Critical Care summit, January 26-27, 2007"},{"title3":"Altevogt BM, Institute of Medicine. (U.S.). Committee on Guidance for Establishing Standards of Care for Use in Disaster Situations. Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations: A Letter Report. Washington, DC: National Academies Press; 2009."},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: a framework for allocation of scarce resources in mass critical care: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: medical resources for surge capacity: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Task Force for Mass Critical Care. Definitive care for the critically ill during a disaster: a framework for optimizing critical care surge capacity: from a Task Force for Mass Critical Care summit meeting, January 26-27, 2007, Chicago, IL"},{"title3":"Survey about responsiveness of third-level hospitals to a medical disaster: after the pandemic influenza in Mexico [in Spanish]"},{"title3":"H1N1 influenza: critical care aspects"},{"title3":"Hospital Civil de Guadalajara, Fray Antonio Alcalde Emerging Respiratory Infections Response Team. Hospital triage system for adult patients using an influenza-like illness scoring system during the 2009 pandemic:Mexico"},{"title3":"Preparing your intensive care unit for the second wave of H1N1 and future surges"},{"title3":"Planning for a pandemic: a view from the accident and emergency department"},{"title3":"Preparing for the sickest patients with 2009 influenza A(H1N1)"},{"title3":"Influenza A(H1N1) epidemic in Argentina. Experience in a National General Hospital (Hospital Nacional Profesor Alejandro Posadas) [in Spanish]"},{"title3":"Death toll climbs and healthcare needs escalate in Japan"},{"title3":"Boston's first-in-class first response"},{"title3":"The Boston Marathon response: why did it work so well?"},{"title3":"Emergency preparedness and public health: the lessons of Hurricane Sandy"},{"title3":"Hurricane Sandy and the greater New York health care system"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Chemical weapons. U.N. taps special labs to investigate Syrian attack"},{"title3":"Lack of atropine in Syria hampers treatment after gas attacks [published correction appears in BMJ. 2013;347:f 5530]"},{"title3":"As Syria crisis mounts, scientist looks back at last major chemical attack"},{"title3":"on behalf of the Task Force for Mass Critical Care. Methodology: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement"},{"title3":"Barbera JA, Macintyre AG. Medical and Health Incident Management (MaHIM) System: A Comprehensive Functional System Description for Mass Casualty Medical and Health Incident Management. Washington, DC: Institute for Crisis, Disaster, and Risk Management, George Washington University; 2002"},{"title3":"Barbera JA, Macintyre AG. Medical Surge Capacity and Capability: A Management System for Integrating Medical and Health Resources During Large-Scale Emergencies. Washington, DC: US Department of Health and Human Services; 2004"},{"title3":"Clinical research ethics for critically ill patients: a pandemic proposal"},{"title3":"InFACT: a global critical care research response to H1N1"},{"title3":"PREEDICCT Study Group. Critical care resource allocation: trying to PREEDICCT outcomes without a crystal ball"}]}]},{"title1":"Clinical course of 2019 novel coronavirus disease (COVID-19) in individuals present during the outbreak on the Diamond Princess cruise ship<","References":[{"title2":"COVID-19 first stage in Japan - how we treat Diamond princess cruise ship with 3700 passengers?","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia","References":[]},{"title2":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing","References":[]},{"title2":"A case of coronavirus disease 2019 treated with ciclesonide","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Clinical management of severe acute respiratory infection when COVID-19 disease is suspected. World Health Organization website"},{"title3":"Imaging profile of the COVID-19 infection: radiologic findings and literature review"},{"title3":"Ciclesonide: a review of its use in the management of asthma [published correction appears in Drugs. 2008;68(15):2162]"},{"title3":"In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide"}]},{"title2":"Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: report of three cases","References":[{"title3":"Preprint server"},{"title3":"Preprint server"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]}]},{"title1":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"Critically ill patients with 2009 influenza A(H1N1) in Mexico","References":[]},{"title2":"Critically ill patients with severe acute respiratory syndrome","References":[{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"A comprehensive review of the use and understanding of airway pressure release ventilation"},{"title3":"Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome"},{"title3":"The use of bronchoscopy in critically ill patients: considerations and complications"},{"title3":"Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome"},{"title3":"Safety of research bronchoscopy in critically ill patients"},{"title3":"Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients"},{"title3":"Bronchoscopy in the Intensive Care Unit"},{"title3":"The effect of fibreoptic bronchoscopy in acute respiratory distress syndrome: experimental evidence from a lung model"},{"title3":"Changes in pulmonary mechanics after fiberoptic bronchoalveolar lavage in mechanically ventilated patients"},{"title3":"Effects on respiratory mechanics of bronchoalveolar lavage in mechanically ventilated patients"}]},{"title2":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada","References":[{"title3":"Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study"},{"title3":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?"},{"title3":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model"},{"title3":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses"},{"title3":"Immunogenicity and protective efficacy of influenza vaccination"},{"title3":"Determinants of immunity to influenza infection in man"},{"title3":"Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection"},{"title3":"Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Serological diagnosis of influenza by haemagglutination inhibition testing"},{"title3":"Host adaptive immunity deficiency in severe pandemic influenza"},{"title3":"Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study"},{"title3":"Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations"},{"title3":"Serum and mucosal antibodies fail as prognostic markers during critical influenza A infection"},{"title3":"Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome"},{"title3":"The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness"},{"title3":"Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores"},{"title3":"Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection"},{"title3":"Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia"},{"title3":"Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes"},{"title3":"Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain"},{"title3":"Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States"},{"title3":"Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis"}]},{"title2":"KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city","References":[]},{"title2":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome","References":[{"title3":"Acute respiratory distress syndrome: the Berlin definition"},{"title3":"A comprehensive review of the use and understanding of airway pressure release ventilation"},{"title3":"Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome"},{"title3":"The use of bronchoscopy in critically ill patients: considerations and complications"},{"title3":"Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome"},{"title3":"Safety of research bronchoscopy in critically ill patients"},{"title3":"Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients"},{"title3":"Bronchoscopy in the Intensive Care Unit"},{"title3":"The effect of fibreoptic bronchoscopy in acute respiratory distress syndrome: experimental evidence from a lung model"},{"title3":"Changes in pulmonary mechanics after fiberoptic bronchoalveolar lavage in mechanically ventilated patients"},{"title3":"Effects on respiratory mechanics of bronchoalveolar lavage in mechanically ventilated patients"}]},{"title2":"Short-term outcome of critically ill patients with severe acute respiratory syndrome","References":[{"title3":"Centers for Disease Control and Prevention (2003) Updated interim US case definition for severe acute respiratory syndrome (SARS)-update, 30 April 2003 http://www.cdc.gov/ncidod/sars/casedefinition.htm"},{"title3":"Leigh JM (1990) Oxygen therapy. In: Scurr C, Feldman S, Soni N (eds) Scientific foundations of anaesthesia, 4th edn. Heinemann Medical Books, Oxford, pp 287-296"}]},{"title2":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection","References":[]},{"title2":"SARS and MERS: recent insights into emerging coronaviruses","References":[{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"WHO. Summary of probably SARS cases with onset of illness from 1 November 2002 to 31 July 2003. WHO, http://www.who.int/csr/sars/country/table2004_04_21/en/ (2004)."},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Patient with new strain of coronavirus is treated in intensive care at London hospital"},{"title3":"Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res. Perspect.6, 269-278 (2015)."},{"title3":"WHO. Coronavirus infections: disease outbreak news. WHO, http://www.who.int/csr/don/26-april-2016-mers-saudi-arabia/en/ (2016)."},{"title3":"Nidovirus transcription: how to make sense...?"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Coronaviruses: an overview of their replication and pathogenesis"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"Infidelity of SARS-CoV nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Review of bats and SARS"},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS"},{"title3":"Middle East respiratory syndrome coronavirus neutralizing serum antibodies in dromedary camels: a comparative serological study"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"MERS coronavirus in dromedary camel herd, Saudi Arabia"},{"title3":"Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014"},{"title3":"MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997"},{"title3":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea"},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission"},{"title3":"Middle East respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases"},{"title3":"Biomarkers in acute respiratory distress syndrome"},{"title3":"The mercurial nature of neutrophils: still an enigma in ARDS?"},{"title3":"SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the Collaborative Cross"},{"title3":"Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"In vitro reconstitution of SARS-coronavirus mRNA cap methylation"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-O-methyltransferase activity"},{"title3":"Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments"},{"title3":"The nucleocapsid protein of coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells"},{"title3":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response"},{"title3":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity"},{"title3":"Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression"},{"title3":"SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage"},{"title3":"A two-pronged strategy to suppress host protein synthesis by SARS coronavirus nsp1 protein"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Middle East respiratory syndrome coronavirus nsp1 inhibits host gene expression by selectively targeting mRNAs transcribed in the nucleus while sparing mRNAs of cytoplasmic origin"},{"title3":"Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"MAVS-mediated apoptosis and its inhibition by viral proteins"},{"title3":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses"},{"title3":"Mechanisms of action of ribavirin against distinct viruses"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Clinical analysis of the first patient with imported Middle East respiratory syndrome in China"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts"},{"title3":"Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a non-human primate model of common marmoset"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Middle East respiratory syndrome-coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"Kim, U. J., Won, E. J., Kee, S. J., Jung, S. I. &amp; Jang, H. C. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report. Antivir. Ther.10.3851/IMP3002 (2015)."},{"title3":"Rhee, J. Y., Hong, G. &amp; Ryu, K. M. Clinical implications of five cases of Middle East respiratory syndrome coronavirus infection in South Korea Outbreak. Jpn J. Infect. Dis.10.7883/yoken.JJID.2015.445 (2016)."},{"title3":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design"},{"title3":"Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus"},{"title3":"Ligand-induced dimerization of Middle East respiratory syndrome (MERS) coronavirus nsp5 protease (3CLpro): implications for nsp5 regulation and the development of antivirals"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"International Severe Acute Respiratory &amp; Emerging Infection Consortium. Treatment of MERS-CoV: decision support tool. International Severe Acute Respiratory &amp; Emerging Infection Consortium, https://isaric.tghn.org/site_media/media/articles/Decision_Support_Document_v1_1_20130729.pdf (updated 29 July 2013)."},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein"},{"title3":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Prophylaxis with a MERS-CoV-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012"},{"title3":"Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody"},{"title3":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"The role of C5a in acute lung injury induced by highly pathogenic viral infections"},{"title3":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus"},{"title3":"A decade after SARS: strategies for controlling emerging coronaviruses"},{"title3":"SARS vaccines: where are we?"},{"title3":"Middle East respiratory syndrome: current status and future prospects for vaccine development"},{"title3":"Evaluation of candidate vaccine approaches for MERS-CoV"},{"title3":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge"},{"title3":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates"},{"title3":"Immune efficacy of first and repeat trivalent influenza vaccine in healthy subjects and hemodialysis patients"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Middle East respiratory syndrome"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014"},{"title3":"Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis)"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"SARS-like WIV1-CoV poised for human emergence"}]},{"title2":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","References":[]},{"title2":"China built a hospital in 10 days to battle coronavirus","References":[]},{"title2":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"China coronavirus: six questions scientists are asking."}]},{"title2":"Asymptomatic cases complicate efforts","References":[]},{"title2":"Multiple organ infection and the pathogenesis of SARS","References":[{"title3":"World Health Organization. Communicable Disease Surveillance &amp; Response (CSR). Severe Acute Respiratory Syndrome (SARS). Available at: http://www.who.int/csr/sars/en (accessed July 11, 2005)."},{"title3":"World Health Organization. May 1, 2003. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en/."},{"title3":"Lossi L., P. Aimar, E. Beltramo, and A. Merighi. 2002. Immunogold labeling techniques for transmission electron microscopy: applications in cell and molecular biology. Gold and Silver Staining: Techniques in Molecular Morphology. G.W. Hacker and J. Gu, editors. CRC Press, Boca Raton, FL. 147-167"},{"title3":"Shi, S.R., J. Gu, J.F. Turrens, R.J. Cote, and C.R. Taylor. 2000. Development of AR technique: philosophy and theoretical base. Antigen Retrieval. S.R. Shi, J. Gu, C.R. Taylor, editors., Eaton Publishing Co. Natick, MA. 17-39."}]},{"title2":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways","References":[]},{"title2":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","References":[{"title3":"Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses"},{"title3":"DNA vaccination: transfection and activation of dendritic cells as key events for immunity"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Antibody response and disease severity in healthcare worker MERS survivors"},{"title3":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia"},{"title3":"High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection"},{"title3":"Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals"},{"title3":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection"},{"title3":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex"},{"title3":"Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant"},{"title3":"Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T Lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Rooting the phylogenetic tree of Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Characteristics of traveler with Middle East respiratory syndrome, China, 2015"},{"title3":"The HLA-A2-supermotif: a QSAR definition"},{"title3":"The spike protein of SARS-CoV-a target for vaccine and therapeutic development"},{"title3":"Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC"},{"title3":"Vaccines for the prevention against the threat of MERS-CoV"},{"title3":"A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity"},{"title3":"Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells"},{"title3":"Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection"},{"title3":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses"},{"title3":"Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus"},{"title3":"Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses"},{"title3":"Improved transgenic mouse model for studying HLA class I antigen presentation"},{"title3":"Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling"},{"title3":"Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA"},{"title3":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States"},{"title3":"Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen"},{"title3":"Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus"},{"title3":"Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms"},{"title3":"Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Identification of an epitope of SARS-coronavirus nucleocapsid protein"},{"title3":"Functional and structural definition of a clustering region of HLA-A2-restricted cytotoxic T lymphocyte epitopes"},{"title3":"The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes"},{"title3":"Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein"},{"title3":"Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development"},{"title3":"Characterization of human alphabetaTCR repertoire and discovery of D-D fusion in TCRbeta chains"},{"title3":"Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome"},{"title3":"Protective T-cell responses featured by concordant recognition of MERS-CoV-derived CD8+ T-cell epitopes and host MHC"},{"title3":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV"},{"title3":"Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV"},{"title3":"Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent"},{"title3":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity"},{"title3":"Serological assays for emerging coronaviruses: challenges and pitfalls"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"The structure and function of CD26 in the T-cell immune response"},{"title3":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope"},{"title3":"Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice"},{"title3":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea"},{"title3":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients"},{"title3":"Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Specific serology for emerging human coronaviruses by protein microarray"},{"title3":"Geographic distribution of MERS coronavirus among dromedary camels, Africa"},{"title3":"Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity"},{"title3":"Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"A comprehensive comparison of transmembrane domains reveals organelle-specific properties"},{"title3":"Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system"},{"title3":"MERS in South Korea and China: a potential outbreak threat?"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes"},{"title3":"Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats"},{"title3":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"From SARS coronavirus to novel animal and human coronaviruses"},{"title3":"Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes"},{"title3":"HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Middle East respiratory syndrome and severe acute respiratory syndrome"},{"title3":"Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein"},{"title3":"Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Serological study of an imported case of Middle East respiratory syndrome and his close contacts in China, 2015"},{"title3":"Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis"},{"title3":"T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia"},{"title3":"Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein"},{"title3":"Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen"},{"title3":"Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Current advancements and potential strategies in the development of MERS-CoV vaccines"},{"title3":"Frequency, private specificity, and cross-reactivity of preexisting hepatitis C virus (HCV)-Specific CD8+ T cells in HCV-seronegative individuals: implications for vaccine responses"},{"title3":"Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses"},{"title3":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice"},{"title3":"The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8(+) T cells are augmented in varying degrees by CpG ODN, PolyI: C and R848"},{"title3":"CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein"},{"title3":"Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes"},{"title3":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"}]},{"title2":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study","References":[]},{"title2":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","References":[]}]}]}